SQZ Biotechnologies (SQZ)
NYSE: SQZ
· Real-Time Price · USD
0.43
0.16 (59.26%)
At close: Jul 03, 2023, 5:00 PM
59.26% (1D)
| Bid | n/a |
| Market Cap | 12.83M |
| Revenue (ttm) | 12.2M |
| Net Income (ttm) | -3.4M |
| EPS (ttm) | -2.16 |
| PE Ratio (ttm) | -0.2013888888888889 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | n/a |
| Volume | 30,141,624 |
| Avg. Volume (20D) | 553,611 |
| Open | 0.41 |
| Previous Close | 0.27 |
| Day's Range | 0.38 - 0.57 |
| 52-Week Range | 0.25 - 3.56 |
| Beta | 2.71 |
About SQZ
SQZ Biotechnologies Company, a clinical-stage biotechnology company, develops cell therapies for patients with cancer, autoimmune, infectious diseases, and other serious conditions. Its lead product candidate is SQZ-PBMC-HPV, from its SQZ Antigen Presenting Cells platform, which is in a Phase I clinical trial as a monotherapy and in combination with other immuno-oncology agents for the treatment of HPV16+ advanced or metastatic solid tumors, incl...
Industry Biotechnology
Sector Healthcare
IPO Date Oct 30, 2020
Employees 53
Stock Exchange NYSE
Ticker Symbol SQZ
Website https://www.sqzbiotech.com
2 months ago · proactiveinvestors.co.uk
Serica Energy shares drop as Triton suspended until mid-MarchSerica Energy PLC (AIM:SQZ) shares dropped in Tuesday's early deals after it announced the suspension of production at the Triton FPSO. The company revealed that maintenance and repair work in the wak...